Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$21.32 - $34.81 $166,359 - $271,622
-7,803 Reduced 3.83%
195,958 $5.73 Billion
Q4 2023

Jan 29, 2024

SELL
$19.97 - $24.53 $42,216 - $51,856
-2,114 Reduced 1.03%
203,761 $4.54 Billion
Q3 2023

Oct 24, 2023

SELL
$24.36 - $28.18 $99,169 - $114,720
-4,071 Reduced 1.94%
205,875 $5.1 Billion
Q2 2023

Aug 03, 2023

BUY
$21.38 - $29.19 $69,100 - $94,342
3,232 Added 1.56%
209,946 $5.95 Billion
Q1 2023

May 09, 2023

BUY
$21.74 - $30.93 $4.49 Million - $6.39 Million
206,714 New
206,714 $4.75 Billion
Q4 2022

Feb 14, 2023

BUY
$24.81 - $31.52 $5.1 Million - $6.48 Million
205,667 New
205,667 $5.78 Million
Q3 2022

Nov 14, 2022

BUY
$19.51 - $34.14 $398,199 - $696,797
20,410 Added 6.79%
320,959 $9.08 Million
Q2 2022

Aug 15, 2022

SELL
$17.06 - $31.42 $1.17 Million - $2.15 Million
-68,369 Reduced 18.53%
300,549 $6.66 Million
Q1 2022

May 11, 2022

SELL
$26.68 - $34.81 $6,056 - $7,901
-227 Reduced 0.06%
368,918 $10.7 Million
Q4 2021

Feb 11, 2022

BUY
$29.58 - $49.78 $2.65 Million - $4.47 Million
89,698 Added 32.1%
369,145 $12.1 Million
Q3 2021

Nov 12, 2021

BUY
$41.92 - $58.18 $67,197 - $93,262
1,603 Added 0.58%
279,447 $12.9 Million
Q2 2021

Aug 11, 2021

BUY
$52.06 - $61.27 $2.74 Million - $3.23 Million
52,681 Added 23.4%
277,844 $15.3 Million
Q1 2021

May 13, 2021

SELL
$44.23 - $57.5 $495,154 - $643,712
-11,195 Reduced 4.74%
225,163 $11.6 Million
Q4 2020

Feb 09, 2021

SELL
$33.21 - $46.54 $160,005 - $224,229
-4,818 Reduced 2.0%
236,358 $10.2 Million
Q3 2020

Nov 12, 2020

BUY
$33.87 - $55.93 $161,559 - $266,786
4,770 Added 2.02%
241,176 $8.44 Million
Q2 2020

Aug 12, 2020

BUY
$34.45 - $53.48 $358,107 - $555,924
10,395 Added 4.6%
236,406 $12.6 Million
Q1 2020

May 06, 2020

BUY
$31.52 - $53.81 $271,103 - $462,819
8,601 Added 3.96%
226,011 $8.02 Million
Q4 2019

Feb 14, 2020

BUY
$30.08 - $50.59 $580,724 - $976,690
19,306 Added 9.75%
217,410 $10.4 Million
Q3 2019

Nov 07, 2019

SELL
$32.4 - $49.58 $260,496 - $398,623
-8,040 Reduced 3.9%
198,104 $6.42 Million
Q2 2019

Aug 12, 2019

SELL
$46.17 - $68.1 $239,483 - $353,234
-5,187 Reduced 2.45%
206,144 $10.3 Million
Q1 2019

May 14, 2019

BUY
$45.92 - $67.67 $53,267 - $78,497
1,160 Added 0.55%
211,331 $14.3 Million
Q4 2018

Feb 11, 2019

SELL
$42.73 - $76.53 $218,820 - $391,910
-5,121 Reduced 2.38%
210,171 $9.69 Million
Q3 2018

Nov 09, 2018

BUY
$71.67 - $91.95 $183,403 - $235,300
2,559 Added 1.2%
215,292 $0
Q2 2018

Aug 06, 2018

BUY
$73.22 - $99.55 $451,694 - $614,123
6,169 Added 2.99%
212,733 $17.9 Million
Q1 2018

May 15, 2018

BUY
$59.83 - $86.53 $1.95 Million - $2.82 Million
32,535 Added 18.7%
206,564 $16.9 Million
Q4 2017

Feb 09, 2018

BUY
$52.12 - $72.33 $9.07 Million - $12.6 Million
174,029
174,029 $9.95 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.05B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.